StonvexLoading…
StonvexStonvexStonvexCore line items from LMND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $737.90M | $526.50M | $429.80M | $256.70M |
Operating Income | $-160.90M | $-203.90M | $-229.80M | $-294.80M |
Net Income | $-165.50M | $-202.20M | $-236.90M | $-297.80M |
EPS (Diluted) | $-2.24 | $-2.85 | $-3.40 | $-4.59 |
Total Assets | $1.93B | $1.85B | $1.63B | $1.69B |
Total Liabilities | $1.39B | $1.26B | $924.40M | $823.90M |
Cash & Equivalents | $385.00M | $376.00M | $264.50M | $282.50M |
Free Cash Flow OCF − CapEx | $-25.90M | $-20.80M | $-128.30M | $-173.10M |
Shares Outstanding | 75.91M | 72.72M | 70.16M | 69.28M |